SCHEMBL10310593

SCHEMBL10310593

CCOC(=O)NCCCCC(NC(=O)OCC)C(=O)NC(C)NC(=O)C(C)N1C(=O)C=CC1=O

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SIRT2 Q8IXJ6 9/20 0.41
▸ SIRT1 Q96EB6 7/20 0.41
▸ HDAC4 P56524 2/20 0.39
▸ EP300 Q09472 1/20 0.39
▸ MEF2D Q14814 1/20 0.39
▸ CPB1 P15086 1/20 0.38
▸ CPB2 Q96IY4 1/20 0.38
▸ SIRT3 Q9NTG7 5/20 0.37
▸ SIRT5 Q9NXA8 1/20 0.37
▸ HDAC3 O15379 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC10 Q969S8 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36
▸ HDAC5 Q9UQL6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20010470 0.93 SIRT2 (0.39) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL11955676 0.90 SIRT2 (0.37) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL327667 0.88 SIRT1 (0.36) SIRT2SIRT1CPB1CPB2SIRT3
SCHEMBL12497446 0.86 CPB1 (0.36) SIRT2SIRT1CPB1CPB2SIRT5
SCHEMBL12437824 0.86 ALDH1A1 (0.37) HDAC4EP300MEF2D
SCHEMBL13531987 0.84 SIRT2 (0.41) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL12509123 0.84 SIRT1 (0.34) SIRT1CPB1CPB2
SCHEMBL11998881 0.82 SIRT2 (0.36) SIRT2SIRT1HDAC4EP300MEF2D
SCHEMBL13367216 0.82 SIRT5 (0.33) SIRT2SIRT1CPB1CPB2SIRT5
SCHEMBL11955643 0.82 SIRT2 (0.43) SIRT2SIRT1HDAC4EP300MEF2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170283552-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2017-10-05 — — US disclosed
US-9334364-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2016-05-10 — — US disclosed
US-8889831-B2 Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate NEKTAR THERAPEUTICS (US) 2014-11-18 — — US disclosed
US-20140323742-A1 METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS NEKTAR THERAPEUTICS 2014-10-30 — — US disclosed
US-8461295-B2 Methods for preparing polymeric reagents and compositions of polymeric reagents NEKTAR THERAPEUTICS (US) 2013-06-11 — — US disclosed
US-20120214952-A1 Methods for Preparing Polymeric Reagents and Compositions of Polymeric Reagents NEKTAR THERAPEUTICS (US) 2012-08-23 — — US disclosed
US-20120178692-A1 DOSAGE FORMS OF POLYMER-FACTOR VIII MOIETY CONJUGATES NEKTAR THERAPEUTICS (US) 2012-07-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178692-A1 DOSAGE FORMS OF POLYMER-FACTOR VIII MOIETY CONJUGATES F8, F9, F13B SIRT2 4051/4885SIRT1 4220/4885HDAC4 3714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback